More Harm than Good?
暂无分享，去创建一个
[1] C. Ko,et al. Reply to Letter: "Ability to Prevent Death as a Sequelae of Morbidity May Be an Additional Indicator of Hospital Quality". , 2015, Annals of surgery.
[2] C. Ko,et al. Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer , 2014, Annals of surgery.
[3] M. Büchler,et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Jeffrey E. Lee,et al. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival , 2013, Journal of Gastrointestinal Surgery.